Condition: Episodic Migraine · Sponsor: H. Lundbeck A/S
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
This description comes directly from the study's public registry record.
Email contact via H. Lundbeck A/S · +45 36301311 · HQ_Medinfo@Lundbeck.com
Always discuss trial participation with your own doctor first.
| Ki Health Partners LLC DBA New England Institute for Clinical Research | Stamford, Connecticut, United States | Recruiting |
| Child Neurology of NW Florida | Gulf Breeze, Florida, United States | Recruiting |
| AGA Clinical Trials - Hialeah - 4980 W 10th Ave | Hialeah, Florida, United States | Recruiting |
| University of South Florida - 13330 USF Laurel Dr | Tampa, Florida, United States | Recruiting |
| Clinical Integrative Research Center of Atlanta | Atlanta, Georgia, United States | Recruiting |
| University of Kentucky HealthCare (UKHC) Kentucky Clinic | Lexington, Kentucky, United States | Completed |
| University of Maryland School of Medicine | Baltimore, Maryland, United States | Completed |
| Michigan Head Pain and Neurological Institute | Ann Arbor, Michigan, United States | Completed |
| North Suffolk Neurology-Commack | Commack, New York, United States | Completed |
| OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte | Charlotte, North Carolina, United States | Completed |
| Childrens Hospital Medical Center of Akron | Akron, Ohio, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center - PIN | Cincinnati, Ohio, United States | Recruiting |
+ 53 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05897320